Rigel Pharma (RIGL) Tops Q2 EPS by 12c
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $48.67 --0%
EPS Growth %: -34.9%
Financial Fact:
Interest income: 110K
Today's EPS Names:
CAN, UNFI, SUNB, More
EPS Growth %: -34.9%
Financial Fact:
Interest income: 110K
Today's EPS Names:
CAN, UNFI, SUNB, More
Join SI Premium – FREE
Rigel Pharma (NASDAQ: RIGL) reported Q2 EPS of $0.04, $0.12 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $26.89 million versus the consensus estimate of $25.7 million.
For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Citi upgrades C.H. Robinson to Buy with $185 target, Opens 90-Day upside catalyst watch
- UBS Upgrades Eaton Corporation (ETN) to Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
